Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Audentes Therapeutics
company
About
Audentes is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases.
- 251 - 500
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $30M
- Industries
- Biotechnology,Genetics,Health Care,Health Diagnostics
- Founded date
- Jan 1, 2013
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Audentes Therapeutics doing business as Astellas Gene Therapies, Inc. is a biotechnology company that serves as the Gene Therapy Center of Excellence. The company is divided into three divisions that specialize in gene therapy research, including technical operations, medical and development, and future commercialization of gene therapy programs.Audentes Therapeutics was acquired by Astellas Pharma on January 15, 2020.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$137.50M
Audentes Therapeutics has raised a total of
$137.50M
in funding over 2 rounds. Their latest funding was raised on
Oct 13, 2015 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 13, 2015 | Series C | $65M | 1 | — | — | Detail |
| Dec 2, 2014 | Series B | $42.50M | 1 | — | — | Detail |
| Jul 18, 2013 | Series A | $30M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Audentes Therapeutics is funded by 1 investors.
Versant Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Versant Ventures
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
